(PCH)
LONG-ACTING-INSULIN-287(PCH)
NNC0148-0287(PCH)
CAS 1188379-43-2(CA)
INSULIN ICODEC(INNE)
INSULIN-IKODEK(CZ)
HUMAN INSULIN A-CHAIN (1-21) VARIANT (Y>E^14), HUMAN INSULIN B-CHAIN (1-29) VARIANT (Y>H^16, F>H^25) CONJUGATED AT K^29B AT ITS N^6 TO (22S)-22,42-DICARBOXY- 10,19,24-TRIOXO-3,6,12,15-TETRAOXA-9,18,23-TRIAZADOTETRACONTAN-1-OYL; N^6.29B-[(22S)-22,42-DICARBOXY-10,19,24-TRIOXO-3,6,12,15-TETRAOXA-9,18,23-TRIAZADOTETRACONTAN-1-OYL]-[TYR14^A>GLU, TYR16^B>HIS, PHE25^B>HIS]-DES-THR30^B-HUMAN INSULIN; PROPOSED INN: LIST 123, REC. LIST 85(WHO)
(1A-21A),(1B-29B)-INSULIN (HUMAN), 14A-L-GLUTAMIC ACID-16B-L-HISTIDINE-25B-L-HISTIDINE-29B-(N6-(N-(19-CARBOXY-1-OXONONADECYL)-L-GAMMA-GLUTAMYL-2-(2-(2-AMINOETHOXY)ETHOXY)ACETYL-2-(2-(2-AMINOETHOXY)ETHOXY)ACETYL)-L-LYSINE)-(PCHC)
INSULINUM ICODECUM(INN)